Antihypertensive drug effects on long-term blood pressure an individual-level data meta-analysis of randomised clinical trials. |
|
The association between exposure to clozapine, olanzapine, and quetiapine and the outcomes perimyocarditis and heart failure A population-based cohort study. |
|
Association between renin-angiotensin-aldosterone system inhibitor use and COVID-19 hospitalization and death a 1.4 million patient nationwide registry analysis. |
|
Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation An individual participant data meta-analysis. |
|
Blood pressure phenotypes based on ambulatory monitoring in a general middle-aged population |
|
Cardiovascular Outcomes in Patients With Biopsy-proven Alcohol-related Liver Disease |
|
A comparison of echocardiographic and circulating cardiac biomarkers for predicting incident cardiovascular disease |
|
Comparison of Sleeve Gastrectomy vs Intensive Lifestyle Modification in Patients With a BMI of 30 to Less Than 35 |
|
A Comparison of the Nutritional Qualities of Supermarket's Own and Regular Brands of Bread in Sweden |
|
Development and validation of deep learning ECG-based prediction of myocardial infarction in emergency department patients |
|
The Effect of General Adiposity and Central Body Fat Distribution on the Circulating Metabolome a Multi-Cohort Non-Targeted Metabolomics Observational and Mendelian Randomization Study. |
|
Equalization of four cardiovascular risk algorithms after systematic recalibration individual-participant meta-analysis of 86 prospective studies. |
|
Evaluation of time delay between discovery of a high blood pressure in a health screening survey and hypertension diagnosis |
|
A framework for monitoring of new drugs in Sweden |
|
Handbok i biomedicinsk forskning |
|
Health care registers can be instrumental for endpoint capture in clinical diabetes trials example of microvascular complications in Swedish patients with type 2 diabetes. |
|
HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden A registry-based cohort study. |
|
Immunoglobulin A nephropathy and ischemic heart disease a nationwide population-based cohort study. |
|
Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure |
|
Left ventricular hypertrophy and the insulin resistance syndrome |
|
Length of time periods in treatment effect descriptions and willingness to initiate preventive therapy a randomised survey experiment. |
|
Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries 23 million person-years of observation. |
|
Long-term risk of arrhythmias in patients with inflammatory bowel disease A population-based, sibling-controlled cohort study. |
|
Markers of imminent myocardial infarction |
|
Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease Observational and Mendelian Randomization Analyses. |
|
Mortality and Cardiovascular Outcomes in Patients Presenting With Non-ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors Results From the SWEDEHEART Registry. |
|
Multi-ancestry GWAS of the electrocardiographic PR interval identifies 202 loci underlying cardiac conduction |
|
Patients With Microscopic Colitis Are at Higher Risk of Major Adverse Cardiovascular Events A Matched Cohort Study. |
|
Physical activity may compensate for prolonged TV time regarding pulse rate-a cross-sectional study |
|
Plasma Protein Profiling of Incident Cardiovascular Diseases A Multisample Evaluation. |
|
The Precision HYpertenSIon Care (PHYSIC) study a double-blind, randomized, repeated cross-over study. |
|
Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2.4 million patients from 11 countries The CaReMe CKD study. |
|
Proteins associated with incident metabolic syndrome in population-based cohorts |
|
Proteomic, metabolomic, and microbiome studies of blood pressure |
|
Registry-based randomised clinical trials a remedy for evidence-based diabetes care?. |
|
A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST) Rationale, design and protocol. |
|
Renin-Angiotensin Aldosterone System Inhipitors and COVID-19 A Systematic Review and Meta-Analysis Revealing Critical Bias Across a Body of Observational Research. |
|
Risk factors for COVID-19-related death, hospitalization and intensive care a population-wide study of all inhabitants in Stockholm. |
|
Socioeconomic Disparities and Mediators for Recurrent Atherosclerotic Cardiovascular Disease Events After a First Myocardial Infarction |
|
Sodium content in processed food items in Sweden compared to other countries a cross-sectional multinational study. |
|
Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019 a systematic analysis from the Global Burden of Disease Study 2019. |
|
Swedish Covid-19 Investigation for Future Insights-A Population Epidemiology Approach Using Register Linkage (SCIFI-PEARL) |
|
The Swedish military conscription register opportunities for its use in medical research. |
|
Synergistic effects of blood pressure-lowering drugs and statins systematic review and meta-analysis. |
|
Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization |
|
World Health Organization cardiovascular disease risk charts revised models to estimate risk in 21 global regions. |
|